文献速递类风湿关节炎脊柱关节炎其他结缔组织病

慢性疼痛中的中枢敏化:最新发现与精准医学潜力

Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine.
PubMed 文献 · Lancet Rheumatol · 2021-03-30

该综述指出中枢敏化可解释组织损伤程度与疼痛症状之间的不一致,在纤维肌痛、骨关节炎、类风湿关节炎等风湿科常见疼痛疾病中均有记录,且患者间存在显著个体差异。中枢敏化可预测多种人群治疗结局不佳,现有证据支持药物与非药物策略改善结局,并提示按疼痛表型进行精准疼痛医学治疗是合理下一步。

要点

  • 中枢敏化在风湿科多种常见疼痛疾病中被记录,患者间存在显著个体差异。
  • 中枢敏化可预测多种患者人群的治疗结局不佳。
  • 证据支持药物与非药物策略减少中枢敏化并改善结局。

核心结论

  • 中枢敏化可解释组织损伤与疼痛症状程度之间的不一致,并预测多种患者人群治疗结局不佳。
  • 现有证据支持药物与非药物策略减少中枢敏化并改善风湿科常见疾病的患者结局。
  • 按疼痛表型匹配非药物方法或药物或两者,是精准疼痛医学治疗的合理下一步。

研究设计与样本

  • 综述类文章,检索范围未在原文中具体报告。

主要发现

  • 中枢敏化被定义为中枢神经系统内神经信号放大导致痛觉过敏。
  • 纤维肌痛、骨关节炎、类风湿关节炎、Ehlers-Danlos综合征、上肢肌腱病、头痛和脊柱疼痛中记录了中枢敏化特征。
  • 在单个疼痛疾病内,患者间中枢敏化的存在与程度存在显著差异,强调个体评估的重要性。
  • 中枢敏化在多种患者人群中预测治疗结局不佳。

关键数值与推荐

  • 原文未报告具体数值、比例、阈值、剂量、样本量或P值。

临床怎么用

  • 在风湿科常见疼痛疾病中应个体评估中枢敏化的存在与程度。
  • 可考虑药物与非药物策略以减少中枢敏化并改善患者结局。
  • 可根据疼痛表型匹配非药物方法或药物或两者,作为精准疼痛医学的下一步。

局限性

  • 原文未报告综述的检索范围与纳入研究的具体特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic pain is a leading cause of disability globally and associated with enormous health-care costs. The discrepancy between the extent of tissue damage and the magnitude of pain, disability, and associated symptoms represents a diagnostic challenge for rheumatology specialists. Central sensitisation, defined as an amplification of neural signalling within the CNS that elicits pain hypersensitivity, has been investigated as a reason for this discrepancy. Features of central sensitisation have been documented in various pain conditions common in rheumatology practice, including fibromyalgia, osteoarthritis, rheumatoid arthritis, Ehlers-Danlos syndrome, upper extremity tendinopathies, headache, and spinal pain. Within individual pain conditions, there is substantial variation among patients in terms of presence and magnitude of central sensitisation, stressing the importance of individual assessment. Central sensitisation predicts poor treatment outcomes in multiple patient populations. The available evidence supports various pharmacological and non-pharmacological strategies to reduce central sensitisation and to improve patient outcomes in several conditions commonly seen in rheumatology practice. These data open up new treatment perspectives, with the possibility for precision pain medicine treatment according to pain phenotyping as a logical next step. With this view, studies suggest the possibility of matching non-pharmacological approaches, or medications, or both to the central sensitisation pain phenotypes.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Nijs J, George SZ, Clauw DJ, et al. Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine. Lancet Rheumatol. 2021. PMID: 38279393. doi:10.1016/S2665-9913(21)00032-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。